Questo sito potrebbe utilizzare anche cookie di profilazione di terze parti. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, clicca su "Maggiori dettagli". Chiudendo questo banner e proseguendo nella navigazione, acconsenti all'uso dei cookie.
Maggiori dettagli



2nd Verona Expert Meeting Evolving strategies in the management of liver metastases

"Evolving Strategies in the Management of Liver Metastases"

06 lug – 07 lug 2018

Palazzo della Gran Guardia


• Target therapies: sustainability, effectiveness and social impact • Evolution of liver surgery in the new millennium
• Management of LM: Has the future already begun?


• Neoadjuvant treatment of resectable disease, real benefit?
• New predictors of chemotherapy response and of surgical outcomes

• Management of vanishing lesions
• Role of liver resection in patients with extrahepatic disease • Definition of histological margins in liver surgery
• Parenchymal sparing liver resections vs two stage/ALPPS • Role of laparoscopic of liver surgery for CRLM
• What is the optimal approach in multinodular disease?
• Syncronous disease, which timing?

• Liver transplantation of liver metastases: real benefit for unresectable disease?